Congressional record
David Taylor bought Amgen Inc. stock on JUN 5.
David Taylor — a trade near an FDA decision
The FDA recorded a recall (Class II) of a product from Amgen Inc. on JUN 4.
1 day separated the trade and the FDA action.
7 of Taylor's disclosed trades fall within three weeks of an FDA decision.
Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
SOURCE: STOCK ACT DISCLOSURES, HOUSE CLERK · OPENFDA, U.S. FOOD & DRUG ADMINISTRATION